Hyperkalemia Completed Phase 2 Trials for Sodium zirconium cyclosilicate (DB14048)

Back to Hyperkalemia

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03337477A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8Treatment